Although overall MYB transcript levels were not significantly associated with patient survival, patients with specific molecular subtypes of colorectal cancer enriched in stem cell/EMT features (C4 and C6) had significantly longer survival when high MYB expression was detected (Supplementary Fig. S7). This evidence concerns the gene MYB and colorectal cancer.